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Summary: A method is recommended for the measurement of the catalytic concentration of alanine amino-
peptidase in the urine of man, rat, and dog, using L-alanine-4-nitroanilide as substrate. In currently used
methods, substrate concentrations between 1.7 and 2.0 mmol/l are used. Kinetic experiments show, however,
that the reaction is inhibited by substrate concentrations exceeding 0.8 (man), 0.3 (rat) and 0.5 mmol/l (dog);
these concentrations lie in the range of the K^ values. Assay conditions were therefore chosen to give the
lowest possible Km. The K^ value depends on the type of buffer, and it increases with pH and temperature.
The recommended assay conditions are: triethanolamine buffer 70 mmol/l, pH 7.6; L-alanine-4-nitroanilide
concentrations depending on the species (see above); incubation temperature 25 °C.
investigations (2, 3). L-Alanine-4-nitroanilide and L-
Measurements of "alanine aminopeptidase", -ami- alanine-ß-naphthylamide are the commonly used sub-
npacylpeptide hydrolase (EC 3.4.11.2, microsomal), strates for alanine aminopeptidase.
in urine provide a sensitive diagnostic indicator for
renal diseases (1) and are particularly useful for the Kinetic studies showed that L-alanine-4-nitroanilide
recognition and assessment of nephrotoxic side effects inhibits the alanine aminopeptidase reaction in human
of drugs in both animal studies and human clinical urine at concentrations exceeding about 0.8 mmol/l
(3). The commonly used standard substrate concen-
') Report of the working group Clinical Chemistry of Labo- tr*tion of 1.6 mmol/l inhibits alanine aminopeptidase
ratory Animals of the German Society of Clinical Chemistry, by about 10 per cent, but the inhibition may be as
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high as 15 to 20% in some urines. It became necessary,
therefore, to re-examine the assay conditions for alan-
ine aminopeptidase in urine with L-alanine-4-nitroan-
ilide. Since L-alanine-ß-napthylamide also inhibits the
reaction at concentrations exceeding about 0.7 mmol/1
(1. c. (4), p. 37), this substrate was not considered as
an alternative.
The aim of this multi-laboratory investigation was to
optimize the recommended alanine aminopeptidase
assay in urine, for both man and laboratory animals.
Significant differences were found between species
with regard to substrate inhibition, so that the optimal
concentration of L-alanine-4-nitroanilide is different,
depending on whether the assay is performed in the
urine of man, rat, and dog. These substrate concen-




Patient urines were randomly selected from the Clinical Chem-
istry Laboratory. Urines from mature Wistar rats and beagle
dogs were collected from animals housed in metabolic cages in
order to exclude contamination by food and faeces. Water was
supplied ad libitum. During the collection period the urine was
either cooled in ice or preserved by addition of sodium azide
(10 of a 15 mmol/1 solution per 10 ml of urine).
Preparation of urine
Urine was centrifuged for 10 min at 1000 g and the supernatant
(= crude urine) used for gel filtration on ready to use columns,
Sephadex G25, medium (Pharmacia PD 10). Crude urine (2.5
ml) was applied to the column and the eluate was discarded;
after complete drainage, 4.0 ml NaCl 0.15 mol/1 were added;
the total eluate was collected for enzyme analysis; dilution
factor = 1.6 (5).
Enzyme assay
The final concentrations in the incubation medium were:
L-alanine-4-nitroanilide 0.834 mmol/1, unless stated otherwise;
phosphate, Tris or triethanolamine buffer, 70 mmol/1, pH 7.6,
unless stated otherwise;
sample volume fraction 0.2.
Urines with high alanine aminopeptidase catalytic activity con-
centration (see recommendation) were diluted with sodium
chloride, 0.15 mol/1. Liberated 4-nitroaniline was measured at
405 nm in thermoregulated cuvettes at 25 °C.































Median. Experiments with [S] = 0.834 mmol/1.
In the five laboratories the following analysers were used:
1 &5, Flexigem, ENI, Inc.;
2, CentrifiChem 400, Union Carbide;
3, Cobas-Bio, Roche Analytical Systems;





The pH dependence of the alanine aminopeptidase
activity was measured between pH 7.0 and 9.0 in
increments of 0.2. The pH optima with Tris and
triethanolamine buffer are shown in table 1. There
are slight differences between species and between
buffers. Phosphate buffer was used between pH 7.0
and 8.0 without a maximum being reached. Explor-
atory experiments with rhesus monkeys and mini pigs
also show pH optima near 8 with Tris and trieth-
anolamine buffer. In figure 1, two crude and gel-
filtered human urines are compared. The activity ratio
gel filtrate/crude urine (GF/CR) is low in one urine
and high in the other. Note the shift of the pH
optimum to the alkaline side in the urine with the
high gel filtrate/crude urine activity ratio. A high ratio
means a relatively high concentration of inhibitors in
the crude urine. Since amino acids were identified as
naturally occurring alanine aminopeptidase inhibitors
in urine (6), phenylalanine, which has the lowest I0.5
(i. e. the inhibitor concentration which inhibits 50%)
of the amino acids tested, was added to the gel filtrate
of a human urine (fig. 2). This shifted the pH optimum
to the alkaline side. In figure 3 the pH optima are
compared between Vmax and v at [S] = 0.834 mmol/1.
Since Km increases with increasing pH, the pH opti-
mum is shifted to the acid side, depending on the
substrate concentration.
Michäelis-Menten constants
The Km values for L-alanine-4-nitroanilide were cal-
culated by regression analysis from Lineweaver^Burk
plots (1/v vs 1/[S]), with substrate concentrations
ranging from 0.1668 to 16.68 mmol/1. In view of the
inhibition of the alanine aminopeptidase activity by
substrate concentrations exceeding «0.8 mmol/1 with
human urine and « 0.3 — 0.5 mmol/1 with animal
urines, the Km was calculated from the straight part
of the plot at low substrate concentrations (6). See
the discussion for details.
The results for gel filtrate of human urine are given
in table 2. The lowest Km values were obtained in
triethanolamine buffer pH 7.6. The pH-dependent
changes of Km are also demonstrated in figure 3. In
table 3 the Km values are listed for rat and dog urine,
and in both cases the lowest value was found in
triethanolamine buffer.
J. Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 10





























Fig. l. pH dependence of alanine aminopeptidase in crude
(CR) and gel-filtered (GF) human urine. One urine has
a low activity ratio GF/CR (i. e. a low concentration of
natural inhibitors in CR) (CR A, GF Δ), the other a
high activity ratio GF/CR (i. e. a high concentration of
natural inhibitors in CR) (CR o, GF o). Note the shift
of the pH optimum to the alkaline side in CR with the
high inhibitor concentration. Substrate concentration
= 0.834 mmol/1, triethanolamine buffer.
Tab. 2. Km in gel filtrate of human urine with various buffers
Fig. 2. pH dependence of alanine aminopeptidase in a gel fil-
trate of human urine, without (o) and with (o) the
addition of 4 mmol/1 phenylalanine, one of the identified
natural inhibitors (6). Note the shift of the pH optimum
to the alkaline side in the presence of the inhibitor.
Substrate concentration 0.834 mmol/1, triethanolamine
buffer.
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1 Median. Km in mmol/1.





































1 Median. Km expressed in mmol/1.
Fig. 3. pH dependence of alanine aminopeptidase in a gel fil-
trate of human urine. V^ ο, ν at [S] = 0.834 mmol/1
Δ, Km inserted, triethanolamine buffer. The sharp pH-
dependent peaks of Vmax and Km are consistent with an
earlier report (9).
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Stability of alanine aminopeptidäse during
storage
It is the experience of all participating laboratories,
that crude urine can be stored at 4 °C without signi-
ficant loss of activity for only 3-4 days. Freezing
destroys the activity instantly. In contrast, the activity
remains stable for at least three weeks in gel filtrates
frozen at — 20 °C. However, immediate preparation
of gel filtrates may not always be practicable. There-
fore, storage of crude urine with ethylene glycol was
tested and found to be very satisfactory. The results
are listed in table 4. No inhibition of alanine amino-
peptidäse activity by ethylene glycol was observed in
experiments using up to 3 ml of the solvent added to
7 ml crude urine.
Tab. 4. Stability of alanine aminopeptidäse in human and rat
urine
Material Temper- N Day
ature ^
Human urine1 + 4°C 10 3.39
± 2.18
Rat urine1·2 + 4°C 10 11.3
± 7.40
Human urine3 -20 °C 10 3.35
± 2.06
Rat urine2·3 -20 °C 9 8.12
± 4.40
Expressed as U/l, mean ± s
1 8 ml urine + 2 ml ethylene glycol



















3 7 ml urine + 3 ml ethylene glycol
Incubation temperature
The effect of the incubation temperature of the alan-
ine aminopeptidäse activity in human urine is shown
in table 5. It should be noted that the Km rises with
the temperature. Consequently, the Qi0 values are
higher for Vmax than for v at [S] = 0.834 mmol/1. The
temperature effect, 37 °C vs 25 °C, in rat urine was
measured at [S] = 834 mmol/1 only. Urine was col-
lected from six male and five female Wistar rats on
two days, one week apart. There was no statistically
significant difference between the two days and be-
tween sexes, and the results were therefore combined
(N = 22 from 11 animals). The mean activity ratio
37 °C/25 °C was 2.93, s = 0.20. This represents a Q10
of 2.46, which is slightly higher than the values in
table 5 with human urine.











































v* = activity at [S] = 0.834 mmol/1, triethanolamine buffer
pH7.6
Quality control
Imprecision was investigated for within enzyme assay
runs, within and between gel filtration columns and
enzyme assay, and day to day enzyme analyses. The
very satisfactory results are given in tables 6, 7 and
8, respectively. The imprecision did not vary signifi-
cantly between the different instruments used in the
participating laboratories.
Discussion
The discussion of the results of this investigation and
the recommendation will be preceded by a brief review
of other methods that have been used and proposed
for microsomal or particle-bound a-aminoacylpeptide
hydrolases (EC 3.4.11.2), and by a description of the
effect of identified inhibitors on the enzymes.
Tab. 6. Within-run imprecision of alanine aminopeptidäse



















































* [S] (mmol/1) = 1.67
b [S] = 0.83
c [S] = 0.04
d calculated from Lineweaver-Burk plot, Km in mmol/1e U/l
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Tab. 7. Within column and between columns imprecision of gel
filtration and alanine aminopeptidase assays in human
urine










* Ten aliquots were passed through one column, and the gel
was regenerated after each aliquot
b Aliquots were passed through ten individual columns
c U/l










a Commercial quality control preparations were analysed on
ten consecutive working days
b U/l
The name alanine aminopeptidase was introduced in
1967 (7) for aminopeptidases which preferentially hy-
drolyse substrates with N-terminal alanine, such as
L-alanine-ß-naphthylamide (8) and L-alanine-4-ni-
troanilide (9). Substrates with N-terminal L-leucine
are also hydrplysed, but at a slower rate, and L-
leucine-ß-naphthylamide (10) and L-leucine-4-ni-
troanilide (11) were recommended as substrates. Ac-
cordingly, the enzyme is called leucine aminopepti-
dase. The main advantages of the nitroanilides over
the naphthylamides are the possibility of continuous
recording of the release of 4-nitroaniline, and the easy
adaptation of the assay to automated analysers.
Assay conditions, as used with both leucine and alan-
ine nitroanilides, are summarized in table 9. The con-
ditions vary considerably with regard to the choice of
buffer, pH, concentrations of buffer and substrate,
and assay temperature. Of these selected publications,
two (14, 16) recommend standard assay conditions
for human serum, and one (19) for human urine.
According to our results, the recommended concen-
trations of L-alanine-4-nitroanilide for both human
serum (16) and uriije (19) are too high, because the
substrate inhibits the reaction.
Amino acids and ammonia were identified as natural
inhibitors of alanine aminopeptidase in the urine of
man and rat (6) and are quantitatively removed by
gel filtration. In human urine they account for about
one half of the removable inhibition potential.
In experiments with increasing concentrations of L-
alanine-4-nitroanilide, any one of the four types of
Lineweaver-Burk plots shown schematically in figure
4 may be encountered with human and animal urines.
The ideal straight line (a) is only occasionally en-
countered and is found in crude urines with relatively
high inhibitor concentrations, i.e. a relatively high
value for the ratio: gel filtrate activity/crude urine
activity (GF/CR). Urines with low inhibitor concen-
trations (low activity ratio GF/CR) give rise to plot
(b), which is typical for substrate inhibition, and is
invariably obtained with gel filtrates of human urine.
Inhibitions begins at substrate concentrations > 0.8
mmol/1, and is always stronger in the gel filtrate than
in the corresponding crude urine, i. e. after removal
of the endogenous inhibitors from the urine. It was
previously suggested that this effect may be caused













































































































































































* Compiled from selected publications; b LN = leucine-4-nitroanilide, AN = alanine-4-nitroanilide; c Concentration in assay
mixture; d Recommendation for standardization; c Addition of 5 mmol/1 MgCl2; f Addition of 250 mmol/1 NaCl; Addition of
10 mmol/1 MgCl2
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1/IS1
Fig. 4. Types of Lineweaver-Burk plots found with urine gel
filtrates and L-alanine-4-nitroanilide as substrate: (a)
ideal plot; (b) inhibition by substrate; (c) inhibition by
substrate with a "hump" in the plot; observed regularly
with rat urine and some, but not all dog urines; (d)
presence of two distinct enzymes with different Km and
Vnu« values. See text for details.
by the removal of an unidentified activator from the
crude urine by gel filtration (3). Experiments in which
phenylalanine (one of the natural inhibitors in urine)
was added to gel filtrate suggest, however, that the
substrate inhibition may be diminished and abolished
by a competition between substrate and inhibitor at
the inhibitor binding site (6).
Gel filtrates of rat urine give rise to plot (c), which is
characterized by a "hump". In the majority of rat
urines, the ascending limb of the hump begins at a
substrate concentration of > 0.3 mmol/1, in others at
[S] > 0.5 mmol/1. Variations occur in the height (max-
imum inhibition) of the hump, even in urines collected
on consecutive days from the same animal. These
changes appear to follow an approximate six day cycle
(Grätsch, unpublished). The shape of the plot may be
caused by the existence of more than one alanine
aminopeptidase (see below). Only occasionally does
one encounter plot (b) with a rat urine.
The few dog urines that were investigated gave rise
to plot (b); in three gel filtrates substrate inhibition
began at [S] > 0.8 mmol/1 and in one gel filtrate at
[S] > 0.5 mmol/1.
Plot (d) signifies the presence of two distinct enzymes
with different Km values and catalytic concentrations,
and it is occasionally seen in crude urine with high
endogenous inhibitor concentrations, this type of
plot is obtained by adding an inhibitor, e. g. phenyl-
alanine, to gel filtrate (6). Similar results were recently
obtained with rat urine (Grätsch, unpublished); with
increasing amounts of phenylalanine in the reaction
mixture the hump first disappears, and the plot than
inflects downward.
In figure 5 the Lineweaver-Burk' frlots are compared
for the gel-filtrates of human and rat urine, and for
different buffers. Since the Lineweaver-Burk plots with
gel filtrates deviate from linearity at higher substrate
concentrations, the estimation of K^ is restricted to
the extrapolation from the straight part at low sub-
strate concentrations. Although fairly reliable esti-
mates of Km may be expected from such extrapola-
tions, the situation is complicated by the presence of
two alanine aminopeptidases (Ei and E2) in urine, as
has been demonstrated in inhibition experiments with
phenylalanine (6). The Km of E, is low (« 0.1 mmol/1)
and that of E2 is high (« 2 mmol/1), Consequently,
extrapolation of the straight segment of the Line-
weaver-Burk plot at low substrate concentrations
yields Vmax and Km mainly for E^ but as the activity
ratio Ej/Ej varies from urine to urine, so does the
contribution of E2 to the activity at low substrate
concentrations. This may explain the relatively wide
range of Km values which was found (tabs. 2, 3). The
imprecision of the Vmax and determination per se
is low (tab. 6).
Considering the present study and the need for a
recommended procedure for the measurement of alan^
ine aminopeptidase in urine, the following results
should be recalled:
(1) The inhibition of alanine aminopeptidase activity
in human and animal urine by alanine-4-nitroan-
ilide in excess of about 0.8 (man), 0.3 (rat), and
0.5 mmol/1 (dog), is very disadvantageous, be-
cause the apparent Km values lie in the range from
0.2 to 1 mmol/1;
(2) the pH optima differ only slightly between Tris
and triethanolamine buffer (tab. 1);
(3) Kn increases with increasing pH (tab. 2 and fig.
3), and the lowest value was found with trieth-
anolamine buffer (tabs. 2 and 3);
(4) Km also increases with increasing temperature
(tab. 5).
Because of the substrate inhibition, assays cannot be
done at substrate saturation. Therefore, triethanol-
amine was selected, the buffer in which the lowest Km
was found. Since Km is both pH and temperature
dependent, pH 7.6 and 25 °C are recommended.
The recommendation of 25 °C as incubation temper-
ature is not in line with the increasing acceptance of
37 °C for enzyme activity assays, The authors strongly
J. Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 10
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Pig. 5. Determination of V^ and Km in human (left) and rat (right) urine with Tris (top), triethanolamine (middle), and phosphate
buffer (bottom), all at pH 7.6 and 70 mmol/1 final concentration. The same gel filtrate was used with all three buffers.
Deviation from the straight line begins in human urine at [S] > 0.834 mmol/1 and in rat urine at [S] > 0.556 mmol/1. The
first open circle (from the right) deviates over 15% with human urine and over 10% with rat urine from the calculated
regression lines (filled circles).





























































believe, however, that the experimental data of this
investigation justify the exception.
The distinct peaks of Km and pH optimum in figure
3, including the shoulder around pH 8* were also
found in other human urines and in an extract from
human kidney cortex. The results are consistent with
an earlier investigation with a purified aminopepti-
dase from pig kidney (9).
The difference in the onset of the substrate inhibition
between species, [S] > 0.8 mmol/1 in human urine,
[S] > 0.3 - > 0.5 mmol/1 in rat urine, and [S] > 0.5
— > 0.8 mmol/1 in dog urine, does not permit the
recommendation of an alanine aminopeptidase assay
equally suitable for both human and animal urine.
The applicable substrate concentration of 0.8 mmol/1
in human urine is only about 2.5 times higher than
the median Km value of 0.34 in triethanolamine buffer.
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It would therefore not be advisable to lower the
substrate concentration just for the purpose of con-
forming with conditions in animal urines. A substrate
concentration of 0.3 mmol/1 for the rat, and of 0.5
mmol/1 for the dog must be recommended, although
these concentrations are about equal to the respective
Km values.
The results in figure 5 also reveal that not only K^
but also the velocity of the enzyme reaction depends
on the buffer. In human and rat urine the highest
Vraax values were obtained with Tris buffer. However,
because of the differences of Km between buffers, the
velocities at [S] = 0.8 mmol/1 in man, and [S] = 0.3
mmol/1 in the rat with triethanolamine buffer are close
to the velocities in Tris buffer. The species differences,
with respect to the relative activities in different buff-
ers, should also be noted.
The effect that sodium chloride may have on the
activity of alanine aminopeptidase with L-alanine-4-
nitroanilide as substrate appears to be controversial.
With human serum and a substrate concentration of
2 mmol/1, an activity increase of 10 to 20 percent with
250 mmol/1 sodium chloride was found in one study
(17) but not in another (16); the Km was not affected
(17). The activity was only insignificantly increased
in a gel filtrate of human urine under comparable
assay conditions (19). In the present investigation
Sephadex columns are used equilibrated with 150
mmol/1 sodium chloride, and urine as eluted with the
same solution. The gel filtrate of rat urine was found
to contain on average (in mmol/1) 135 sodium and
128 chloride ions, and < 1 potassium, phosphate and
bicarbonate ions. Gel filtrate of human urine con-
tained on average 120 mmol/1 chloride ions; other
ions were not determined. With the recommended
sample volume fraction of 0.2, the sodium chloride
concentration in the assay mixture amounts to about
25 mmol/1. Sodium chloride added to the assay mix-
ture in a final concentration of 250 mmol/1 increased
the Vmax of alanine aminopeptidase in a gel filtrate of
human urine by 20 percent, and the Km from 0.3 to
0.4 mmol/1. Consequently, the positive effect of so-
dium chloride on the activity was only about 7 percent
at the recommended substrate concentration of 0.8
mmol/1. Since Km had to be kept as low as possible
in the recommended method, addition of sodium chlo-
ride to the assay was not considered.
The results of urine preservation by storage of gel
filtrates at —20 °C are in agreement with earlier re-
ports (19, 23). Crude urine mixed with ethylene glycol
or glycerol and stored at -20°C also provides a
stable quality control material (24).
Intentionally, this recommendation does not comment
on the pros and cons of timed or untimed urine
collection, the problem of diuresis-dependency, and
the appropriate basis of reference (e. g. urinary cre-
atinine). This problem applies to most macromole-
cular analytes in urine and is still under discussion
(25, 26).
Recommendation
Please note in the following recommendation, that
storage and preparation for enzyme analysis are iden^
tical for human and animal urine. In the alanine
aminopeptidase assay, however, the substrate concen^
trations differ and are specific for man, rat and dog.
Urine collection
Human urine should be collected without the addition
of a preservative. During collection periods exceeding
about 3 h the collection bottle should be kept in a
refrigerator.
Animal urine should be collected from animals housed
individually in metabolic cages. During the collection
period the urine should be cooled in ice or preserved
by the addition of sodium azide (10 μΐ of a 15 mmol/1
solution per 10 ml of urine).
Rats excrete 5 — 10 ml of urine per 24 h. However,
after placing a rat in a metabolic cage, the urine
volume is often reduced to less than 1 ml during the
first few days. Therefore, urine collection should begin
4—5 days after caging, provided the experimental
protocol permits this delay.
Urine storage
Crude urine
Centrifuge the urine for 10 min at 1000 g. Procedure
A: to 8 ml of the supernatant add 2 ml of ethylene
glycol (E. Merck, Darmstadt, art. no. 9621, analytical
grade). Store at 4 °C. Procedure B: Alternatively, to
7 ml of the supernatant add 3 ml ethylene glycol. Store
at —20 °C. Scale down either procedure for smaller
urine volumes. The dilution factor of 1.25 (procedure
A) or 1.43 (procedure B) must be considered in the
final calculation of the enzyme activity.
Gel filtrate
Gel filtrate may be stored at -r20°C without any
additive. · »
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Urine preparation
Allow stored urine to reach room temperature. Cen-
trifuge fresh urine as described above. For gel filtra-
tion on "ready to use" columns of Sephadex G25
medium (Pharmacia PD 10), apply 2.50 ml superna-
tant, drain completely, and discard the eluate. Add
4.0 ml 0.15 mol/1 NaCl. The total eluate is collected
and used for the enzyme analysis.
Enzyme assay for human urine
Prepare incubation mixture in cuvettes (d = 1.0 cm)
and read or record absorbance changes in a spectro-
photometer or spectrum-line photometer at 405 nm.












Read or record absorbance for 3 min (longer with
low activities).
Calculation
Alanine aminopeptidase U/l =
ΔΑΔΑ 10s 500
At X 990 X 100 χ 505 (χ dilution factor)
where 990 m2/mol is the molar lineic absorbance of
4-nitroaniline at 405 nm.
Enzyme assay for animal urines
For animal urines lower substrate concentrations
must be recommended, .because of the onset of sub-
strate inhibition at concentrations lower than in hu-
man urine. Otherwise the assay remains the same as
with human urine.
The recommended final concentrations of L-alanine-
4-nitroanilide are 0.3 mmol/1 for rat, and 0.5 mmol/1
for dog urine.
Notes
Because the recommended substrate concentrations
are low with reference to the Km values, special care
must be taken not to exceed about 5 percent hydrol-
ysis of the substrate.
Examples, assuming a 3 min incubation pe-
riod
Human urine: Median value of Km = 0.34, and
[S] = 0.8 mmol/1. Total Δ A should not exceed 0.400.
ΔΑ/3 min = 0.400, ΔΑ/min = 0.133 orO.133 χ 505
χ 1.6 = 107 U/l.
Rat urine: Median value of Km = 0.19, and [S] = 0.3
mmol/1. Total ΔΑ should not exceed 0.150. ΔΑ/3 min
= 0.150, ΔΑ/min =0.050 or 0.050 χ 505 χ 1.6
= 40 U/l.
Dog urine: Median value of Km = 0.44, and [S] = 0.5
mmol/1. Total ΔΑ should not exceed 0.250. ΔΑ/3 min
= 0.250, ΔΑ/min = 0.083 or 0.083 χ 505 χ 1.6
= 67 U/l.
For urines mixed with ethylene glycol for storage, the
appropriate additional dilution factor of 1.25 (pro-
cedure A) or 1.43 (procedure B, see urine storage)
must be applied. If necessary, the gel filtrate should
be diluted with saline.
Caution is also advised in the interpretation of results
from experimental studies with animals and diagnos-
tic applications with patients. In addition to the al-
ready disadvantageous ratio of substrate concentra-
tion to ATm, the established Km values vary over a
relatively wide range (the dog appears to be an ex-
ception, but urines were studied from only 4 animals,
compared with 15 human urines and 32 from the rat).














































































J. Clin. Chem. Clin, Biochem. / Vol. 26,1988 / No. 10
644 Mattenheimer et al.: Measurement of urinary alanine aminopepiidase
Table 10 lists the alanine aminopeptidase activities as
fractions of Vmax at the recommended substrate con-
centrations, calculated with the intermediate, lowest,
and highest Km for each species (Km values from tabs.
2 and 3). Small activity changes, i.e. 17% in human
and rat urine, may lie, therefore, within a normal
biological variation. The last column shows that the
decrease of activity after hydrolysis of five per cent
of substrate is within acceptable limits.
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